Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
August 2022
in “
JAMA Dermatology
”
TLDR Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.
This study involving 1,074 patients with alopecia areata (AA) found that most participants preferred to make treatment decisions collaboratively with their dermatologist through shared decision-making (SDM). The use of SDM was associated with lower decisional regret, particularly when newer treatments like Janus kinase inhibitors were chosen. The survey revealed that when dermatologists explained treatment options and asked for patient preferences, decisional regret decreased. The study suggested that implementing SDM could enhance patient satisfaction and the quality of treatment decisions, and recommended further research to integrate SDM into evolving AA treatment strategies.